Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosylate for Painless Gastroscopy in High-Altitude Patients
ChiCTR2000035604Phase 4Not yet recruiting
- Sponsor
- Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam in None (2 arms), sponsored by Hospital of Chengdu Office of the People's Government of Tibet Autonomous Region. Primary endpoints: Respiratory rate, Blood pressure and 2 more. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2000035604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035604.